title: Thrombin induces thrombomodulin mRNA expression via the proteolytically activated thrombin receptor in cultured bovine smooth muscle cells.
abstract: Thrombin, an important mitogen governing smooth muscle cell proliferation, binds to cultured bovine aortic smooth muscle cells (BASMCs) via both the proteolytically activated thrombin receptor (PATR) and thrombomodulin (TM). Although TM mRNA expression and functional activity is regulated by thrombin in human endothelial cells and mouse hemangioma cells, it remains unclear in those models whether the increased TM mRNA expression observed upon thrombin stimulation is mediated through the activation of PATR or via TM occupancy. We observed in cultured BASMCs that TM mRNA is increased threefold to sixfold by either thrombin, basic fibroblast growth factor (bFGF), or platelet-derived growth factor (PDGF). The increase in TM mRNA with thrombin is time dependent (maximal at 3 hours), a consequence of increased mRNA stability, and accompanied by increases in cell surface TM functional activity. Thrombin-induced TM mRNA was reproduced by the hexameric thrombin receptor-activating peptide (TRAP6) and augmented by a TM-specific antibody. Together, these data suggest that up-regulation of TM mRNA by thrombin is mediated via the PATR. We speculate that increases in BASMC TM mRNA and activity after thrombin may contribute to the impaired thrombus formation observed after atherosclerotic vascular injury.
authors.affiliation: Department of Physiology and Biophysics, Indiana University School of Medicine, Indianapolis, USA.
authors.forename: S F
authors.initials: SF
authors.lastname: Ma
authors.forename: J G
authors.initials: JG
authors.lastname: Garcia
authors.forename: U
authors.initials: U
authors.lastname: Reuning
authors.forename: S P
authors.initials: SP
authors.lastname: Little
authors.forename: N U
authors.initials: NU
authors.lastname: Bang
authors.forename: E P
authors.initials: EP
authors.lastname: Dixon
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001161:Arteriosclerosis / Q000503:physiopathology; D002417:Cattle; D002478:Cells, Cultured; D003001:Cloning, Molecular; D016384:Consensus Sequence; D006224:Cricetinae; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D051379:Mice; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000737:chemistry / Q000502:physiology; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D011956:Receptors, Cell Surface / Q000502:physiology; D018179:Receptors, Thrombin / Q000096:biosynthesis / Q000737:chemistry / Q000502:physiology*; D011994:Recombinant Proteins / Q000096:biosynthesis; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D013917:Thrombin / Q000494:pharmacology*; D018180:Thrombomodulin / Q000096:biosynthesis*; D014158:Transcription, Genetic / Q000187:drug effects*
chemical_list: D000906:Antibodies; D010446:Peptide Fragments; D010982:Platelet-Derived Growth Factor; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D018179:Receptors, Thrombin; D011994:Recombinant Proteins; D018180:Thrombomodulin; C076901:thrombin receptor-activating peptide (P508-530); D016222:Fibroblast Growth Factor 2; D013917:Thrombin